Fujifilm India launch campaign to increase awareness on tuberculosis, Health News, ET HealthWorld

India accounts for more than 1 in 4 of all cases of active TB diseases, including nearly 1.20 lakh cases of drug-resistant forms of TB.

Fujifilm India Pvt Ltd, a multinational medical device maker announced the launch of a national campaign drive to increase awareness and eliminate the spread of tuberculosis in India.

As part of the campaign titled “Never Stop: Screening to Reduce Diagnostic Delays”, the medical device maker aims at increasing awareness on TB and identify individuals having TB symptoms among vulnerable and marginalized sections of the society by introducing a mobile van with an x-ray facility along with a field team and community volunteers.

In line with the government’s mission to make India TB free by 2025, Fujifilm India has launched this campaign in association with National TB Elimination Programme (NTEP). Through its existing network of labs, the NTEP will help in TB testing and provide TB medicines as per the programme guidelines. The International Union Against TB and Lung Disease (The Union), a global leader in lung health, will provide technical support through the United States Agency for International Development’s (USAID iDEFEAT TB Project.

Speaking on the launch of the campaign, Koji Wada, Managing Director, Fujifilm India Pvt Ltd said, “Tuberculosis is a major and growing health concern in India with many people losing their lives every year. We at Fujifilm have always been committed to providing the best healthcare technologies and innovations to make this world a better and healthier place.”

Dr Sudarsan Mandal, DDG TB Central TB Division, said, “India accounts for a quarter of the global TB burden and continues to top the list of patients with tuberculosis, according to a report released by the Global Tuberculosis Report 2020. Our association with Fujifilm India is a step ahead in both public and private sectors to strengthen tuberculosis (TB) diagnostic capacity with Fujifilm’s innovative equipment that will ultimately result in an increase in TB cases identification and hence contribute to eliminate TB in the country by 2025

The campaign is also a part of the ‘Corporate TB Pledge (CTP)’, a USAID supported initiative launched with the Government of India in 2019 to galvanize India’s corporate sector to combat TB, raise awareness of TB as a curable disease, and, ultimately, improve TB health outcomes.

Through the campaign, Fujifilm will be offering door-to-door awareness on TB and provide instant interpretation of mobile digital x-rays using Qure.ai’s artificial intelligence solution. This community-based TB screening initiative will cater to migrant workers, slum dwellers in rural and semi-urban population in and around industrial pockets in selected areas of 25 districts across states, UT Chandigarh, Punjab, Himachal Pradesh, Uttar Pradesh, Uttarakhand, Bihar, West Bengal, Chhattisgarh, Madhya Pradesh and Rajasthan for the next nine months.

The project has partnered with Apollo Tyres Foundation, Ambuja Cement Foundation, GAIL India and TCI Foundation for on-ground community mobilization, sputum collection and transportation. Around nine lakh people will be reached through large-scale mid-media activities to identify symptomatic for conducting x-ray and subsequent TB testing. Existing CTP partners will facilitate community awareness, mobilization and follow-up testing.

Source link